| Dec'19 | Dec'18 | Dec'17 | Dec'16 | |||
|---|---|---|---|---|---|---|
Operating Expenses: | ||||||
Research and development | ||||||
14,102 | 11,119 | 3,816 | 2,966 | |||
General and administrative | ||||||
7,206 | 6,137 | 1,315 | 568 | |||
Total Operating Expenses | ||||||
21,308 | 17,256 | 5,132 | 3,534 | |||
Loss From Operations | ||||||
-21,308 | -17,256 | -5,132 | -3,534 | |||
Other Income: | ||||||
Interest income | ||||||
151 | 3 | 2 | - | |||
Interest income | ||||||
- | - | - | 1 | |||
Net Loss | ||||||
-21,156 | -17,253 | -5,129 | -3,533 | |||
Net Loss Per Share | ||||||
- Basic and Diluted | ||||||
-1.47 | -1.82 | -2.19 | -1.56 | |||
Weighted Average Number of Common Shares Outstanding | ||||||
- Basic and Diluted | ||||||
14,349 | 9,476 | 2,344 | 2,266 | |||